Related Experiment Video
Updated: Jun 26, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Exploiting apoptosis pathways for the treatment of pediatric cancers
1University Children's Hospital, Ulm, Germany. simone.fulda@uniklinik-ulm.de
Abstract:
Resistance to apoptosis (programmed cell death) is a characteristic feature of human cancers including childhood malignancies. Further, evasion of apoptosis is a frequent cause of treatment resistance, since most anti-cancer therapies, for example chemo- or radiotherapy act primarily by inducing apoptosis in cancer cells. Over the last two decades, the dissection of apoptosis pathways in pediatric tumors has resulted in the identification of many key molecules that may serve as molecular targets for drug discovery. Accordingly, components of the apoptotic cascade are currently exploited for the development of rationally designed molecular targeted therapies. This approach is expected to open new and more effective approaches for the treatment of childhood cancers.
Insights
Childhood cancers often resist programmed cell death, a key factor in treatment failure. Targeting apoptosis pathways offers a promising strategy for developing novel molecular therapies against pediatric malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Resistance to apoptosis (programmed cell death) is a hallmark of human cancers, including pediatric malignancies.
- Evasion of apoptosis is a primary mechanism of resistance to conventional anti-cancer therapies like chemotherapy and radiotherapy.
- Understanding apoptosis pathways is crucial for overcoming treatment resistance in cancer.
Purpose of the Study:
- To highlight the significance of apoptosis resistance in pediatric cancers.
- To review the identification of key molecular targets within apoptosis pathways in pediatric tumors.
- To discuss the potential of molecularly targeted therapies for childhood cancers.
Main Methods:
- Dissection of apoptosis pathways in pediatric tumors over the last two decades.
- Identification of key molecules involved in apoptosis as potential drug targets.
- Review of current strategies for developing targeted therapies based on apoptosis components.
Main Results:
- Numerous key molecules regulating apoptosis have been identified in pediatric tumors.
- These identified molecules represent viable targets for novel drug discovery.
- The understanding of apoptosis pathways has advanced significantly in pediatric oncology.
Conclusions:
- Targeting apoptosis pathways is a rational approach for developing new anti-cancer drugs.
- Molecularly targeted therapies hold promise for more effective treatment of childhood cancers.
- Exploiting the apoptotic cascade can lead to improved outcomes for pediatric cancer patients.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy